HealthEquity (NASDAQ: HQY) lists vesting resales; insider sales recorded

Rhea-AI Filing Summary

HealthEquity, Inc. reported proposed resale activity on Form 144 related to Common Stock, primarily tied to restricted stock vesting. The filing lists planned dispositions dated 04/06/2026 and shows recent sales of 739 shares on 01/09/2026 and 7,726 shares on 03/31/2026.

The listed vesting-related lots include 1,541, 244, 344, and 352 shares with a common settlement date of 04/06/2026, indicating multiple small compensation-related dispositions.

Insights

Securities Compliance Analyst

Routine Form 144 notice of proposed resale tied to vesting and recent small sales.

The Form 144 lists multiple restricted-stock vesting lots and records two recent open-market sales: 739 shares (01/09/2026) and 7,726 shares (03/31/2026). These appear to be compensation-related or resale notifications, not an offering prospectus.

Filing mechanics: this notice documents proposed sales under Rule 144; timing and methods of sale beyond the listed dates are not detailed in the excerpt.

Key Figures

Recent sale 1: 739 shares Recent sale 2: 7,726 shares Vesting lot A: 1,541 shares +3 more

6 metrics

Recent sale 1 739 shares sold 01/09/2026 for $142,080.00

Recent sale 2 7,726 shares sold 03/31/2026 for $637,599.31

Vesting lot A 1,541 shares Restricted Stock Vesting dated 04/02/2025; listed with 04/06/2026

Vesting lot B 244 shares Restricted Stock Vesting dated 03/30/2022; listed with 04/06/2026

Vesting lot C 344 shares Restricted Stock Vesting dated 03/27/2024; listed with 04/06/2026

Vesting lot D 352 shares Restricted Stock Vesting dated 03/29/2023; listed with 04/06/2026

Key Terms

Form 144, Restricted Stock Vesting, proposed resale

3 terms

Form 144 regulatory

"Filed notice of proposed sale of securities; lists dates and share counts"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Entries labeled as Restricted Stock Vesting with associated share lots and dates"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

proposed resale regulatory

"Securities To Be Sold section showing planned dispositions dated 04/06/2026"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney 2000 Westchester Ave Purchase NY 10577-2530	2481	207997.77	84478406	04/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/02/2025	Restricted Stock Vesting	ISSUER			1541	04/06/2026	Compensation
Common Stock	03/30/2022	Restricted Stock Vesting	ISSUER			244	04/06/2026	Compensation
Common Stock	03/27/2024	Restricted Stock Vesting	ISSUER			344	04/06/2026	Compensation
Common Stock	03/29/2023	Restricted Stock Vesting	ISSUER			352	04/06/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Delano Ladd C/O HealthEquity, Inc. 15 W. Scenic Pointe Dr. Ste, 100 Draper UT 84020	Common Stock	01/09/2026	739	142080.00
Delano Ladd C/O HealthEquity, Inc. 15 W.Scenic Pointe Dr. Ste, 100 Draper UT 84020	Common Stock	03/31/2026	7726	637599.31

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does HealthEquity's (HQY) Form 144 report?

It reports proposed resales of Common Stock tied to restricted stock vesting and recent sales. The filing lists vesting-related lots scheduled for 04/06/2026 and two past sales of 739 and 7,726 shares.

How many shares were sold recently under HealthEquity (HQY)?

The excerpt shows two sales in the past three months: 739 shares on 01/09/2026 and 7,726 shares on 03/31/2026. Dollar amounts ($142,080 and $637,599.31) are included next to those sales.

Are the proposed sales at HealthEquity (HQY) from compensation or market holdings?

The Form 144 lists multiple entries labeled "Restricted Stock Vesting," indicating the listed lots (1,541; 244; 344; 352 shares) originate from compensation vesting and are being reported for resale.

When are the vesting-related shares for HQY scheduled for resale?

The listed vesting-related lots carry a common date of 04/06/2026 in the excerpt. The filing shows those lots under "Securities To Be Sold" with that date.